风湿免疫指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫指南

2021 国际工作组建议：系统性红斑狼疮缓解的定义

2021-11-08 国外风湿免疫科相关专家小组 Lupus Sci Med

系统性红斑狼疮系统性红斑狼疮缓解

缓解是系统性红斑狼疮（SLE）患者和疾病管理者的既定目标，但疾病患者的定义尚缺乏共识。本文通过系统性的文献回顾，针对系统性红斑狼疮缓解的定义达成共识建议。

中文标题：

2021 国际工作组建议：系统性红斑狼疮缓解的定义

英文标题：

2021 DORIS definition of remission in SLE: final recommendations from an international task force

发布机构：

国外风湿免疫科相关专家小组

发布日期：

2021-11-08

简要介绍：

缓解是系统性红斑狼疮（SLE）患者和疾病管理者的既定目标，但疾病患者的定义尚缺乏共识。本文通过系统性的文献回顾，针对系统性红斑狼疮缓解的定义达成共识建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 国际工作组建议：系统性红斑狼疮缓解的定义.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cc6f41c0022e2786, title=2021 国际工作组建议：系统性红斑狼疮缓解的定义, enTitle=2021 DORIS definition of remission in SLE: final recommendations from an international task force, guiderFrom=Lupus Sci Med, authorId=0, author=, summary=缓解是系统性红斑狼疮（SLE）患者和疾病管理者的既定目标，但疾病患者的定义尚缺乏共识。本文通过系统性的文献回顾，针对系统性红斑狼疮缓解的定义达成共识建议。, cover=https://img.medsci.cn/20211126/1637937424450_1608702.jpg, journalId=0, articlesId=null, associationId=893, associationName=国外风湿免疫科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Mon Nov 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">缓解是系统性红斑狼疮（SLE）患者和疾病管理者的既定目标，但疾病患者的定义尚缺乏共识。本文通过系统性的文献回顾，针对系统性红斑狼疮缓解的定义达成共识建议。</span></p>, tagList=[TagDto(tagId=648, tagName=系统性红斑狼疮), TagDto(tagId=118578, tagName=系统性红斑狼疮缓解)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=648, guiderKeyword=系统性红斑狼疮, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2237, appHits=154, showAppHits=0, pcHits=628, showPcHits=2082, likes=3, shares=7, comments=7, approvalStatus=1, publishedTime=Sun Nov 28 13:46:49 CST 2021, publishedTimeString=2021-11-08, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Fri Nov 26 22:41:07 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 05:11:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 国际工作组建议：系统性红斑狼疮缓解的定义.pdf)])
2021 国际工作组建议：系统性红斑狼疮缓解的定义.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2101476, encodeId=991f21014e6da, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Sat Nov 19 11:31:47 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201101, encodeId=0c6d1201101ad, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Thu Mar 10 00:23:48 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080415, encodeId=bc38108041500, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200901/d760cf0a9f384eb183c16aaa652e9aca/27e1af296c0542728ad85f7167e9d21b.jpg, createdBy=e2725414274, createdName=芷若汀兰, createdTime=Wed Dec 15 20:12:55 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077287, encodeId=7df810e728766, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be65382323, createdName=ms3000001361255440, createdTime=Mon Dec 06 10:27:44 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074941, encodeId=260c10e4941d6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:36 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2022-11-19 LL求知的小罗罗

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2101476, encodeId=991f21014e6da, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Sat Nov 19 11:31:47 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201101, encodeId=0c6d1201101ad, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Thu Mar 10 00:23:48 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080415, encodeId=bc38108041500, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200901/d760cf0a9f384eb183c16aaa652e9aca/27e1af296c0542728ad85f7167e9d21b.jpg, createdBy=e2725414274, createdName=芷若汀兰, createdTime=Wed Dec 15 20:12:55 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077287, encodeId=7df810e728766, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be65382323, createdName=ms3000001361255440, createdTime=Mon Dec 06 10:27:44 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074941, encodeId=260c10e4941d6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:36 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2022-03-10 ms5000001255976811

    学习！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2101476, encodeId=991f21014e6da, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Sat Nov 19 11:31:47 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201101, encodeId=0c6d1201101ad, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Thu Mar 10 00:23:48 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080415, encodeId=bc38108041500, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200901/d760cf0a9f384eb183c16aaa652e9aca/27e1af296c0542728ad85f7167e9d21b.jpg, createdBy=e2725414274, createdName=芷若汀兰, createdTime=Wed Dec 15 20:12:55 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077287, encodeId=7df810e728766, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be65382323, createdName=ms3000001361255440, createdTime=Mon Dec 06 10:27:44 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074941, encodeId=260c10e4941d6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:36 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-12-15 芷若汀兰

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2101476, encodeId=991f21014e6da, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Sat Nov 19 11:31:47 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201101, encodeId=0c6d1201101ad, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Thu Mar 10 00:23:48 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080415, encodeId=bc38108041500, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200901/d760cf0a9f384eb183c16aaa652e9aca/27e1af296c0542728ad85f7167e9d21b.jpg, createdBy=e2725414274, createdName=芷若汀兰, createdTime=Wed Dec 15 20:12:55 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077287, encodeId=7df810e728766, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be65382323, createdName=ms3000001361255440, createdTime=Mon Dec 06 10:27:44 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074941, encodeId=260c10e4941d6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:36 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-12-06 ms3000001361255440

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2101476, encodeId=991f21014e6da, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Sat Nov 19 11:31:47 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201101, encodeId=0c6d1201101ad, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Thu Mar 10 00:23:48 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080415, encodeId=bc38108041500, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200901/d760cf0a9f384eb183c16aaa652e9aca/27e1af296c0542728ad85f7167e9d21b.jpg, createdBy=e2725414274, createdName=芷若汀兰, createdTime=Wed Dec 15 20:12:55 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077287, encodeId=7df810e728766, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be65382323, createdName=ms3000001361255440, createdTime=Mon Dec 06 10:27:44 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074941, encodeId=260c10e4941d6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:36 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-11-29 微探

    学习学习

    0

相关指南

2021 BAD指南：皮肤红斑狼疮患者的管理

英国皮肤科医师协会(BAD,British Association of Dermatologists) · 2021-06-25

2021 APLAR共识声明：系统性红斑狼疮的管理

亚太风湿病学联盟协会(APLAR,Asia Pacific League of Associations for Rheumatology) · 2021-07-01

系统性红斑狼疮达标之路:《2019年欧洲抗风湿病联盟系统性红斑狼疮管理指南》解读

暂未更新 · 2020-05-20

2020中国系统性红斑狼疮诊疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2020-03-30

儿童风湿病国际相关诊治指南系列解读之一—— EULAR-ACR系统性红斑狼疮分类标准解读

暂未更新 · 2020-04-20

2019年EULAR/ACR系统性红斑狼疮分类标准解读

暂未更新 · 2019-11-30

拓展阅读

2010 系统性红斑狼疮诊断及治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2010-05-01

2010 EULAR 治疗有神经精神症状的系统性红斑狼疮患者的推荐意见

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2010-12-01

2011 中国儿童系统性红斑狼疮诊疗建议

中华医学会儿科学分会免疫学组 · 2011-07-01

2014 靶向治疗系统性红斑狼疮：国际工作组推荐建议

国外风湿免疫科相关专家小组 · 2014-04-16

2014 糖皮质激素在系统性红斑狼疮患者合理应用的专家共识

中国系统性红斑狼疮研究协作组(CSTAR,Chinese SLE Treatment And Research Group) · 2014-06-03

风湿免疫疾病( 系统性红斑狼疮) 超药品说明书用药专家共识

广东省药学会 · 2014-09-25